Evidence map›Paper›PMID 31432728›Full record

ArticleCell cycle (Georgetown, Tex.)2019

Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.

Jiang-Hua Dai, Wen-Zhou Huang, Chen Li, Jun Deng, Si-Jian Lin, Jun Luo

RetractedOpen access · bronzeAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. MiR-30 Family: A Novel Avenue for Treating Bone and Joint Diseases?International journal of medical sciences · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Long noncoding RNAAging · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jiang-Hua DaiRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Wen-Zhou HuangRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Chen LiRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Jun DengRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Si-Jian LinRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Jun LuoRehabilitation department, The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi , PR. China.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAnimalsApoptosisBone NeoplasmsCell Line, TumorCell MovementCell ProliferationChildChild, PreschoolFemaleGene SilencingHepatocyte Nuclear Factor 3-alphaHumansMaleMiceFOXA1 protein, humanHepatocyte Nuclear Factor 3-alphalong non-coding RNA SBF2-AS1, humanMicroRNAsMIRN30b microRNA, humanRNA, Long NoncodingapoptosisForkhead box A1invasionLncRNA SBF2-AS1MicroRNA-30amigrationosteosarcomaproliferation

Identifiers

PMID31432728
PMCPMC6773246
OpenAlexW2969387534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.